Goldman Sachs Note on Steve Jobs & Apple (AAPL): Still on Conviction Buy List

Goldman Sachs is out with an updated research note on shares of Apple (AAPL) pending the news that CEO Steve Jobs has taken another medical leave of absence. Today we are focusing on AAPL on the site because according to Goldman, it is the most important stock to hedge funds.

Practically all of the major hedge funds we track have exposure to Apple and for many, it is their top position. We've compiled a list of the top hedge funds that own AAPL here. Combine this with the fact that Steve Jobs IS Apple, you have a potentially volatile situation on your hands. Due to Jobs' medical leave of absence, Goldman expects shares to see near-term weakness. However, they view any dips as a buying opportunity and maintain the stock on their Conviction Buy List.

Goldman's 12-month price target on shares of AAPL is $430. Per the report, "Our target price represents a 19x P/E multiple on our above-consensus CY2010 EPS estimate or a 19% discount to Apple's five-year average multiple of 23x."

Their research essentially outlines 3 reasons that the long-term fundamentals for Apple are still in tact:

1. Tim Cook is a proven leader and step in if Jobs' absence ever became permanent

2. Apple has a massive cash hoard of $51 billion

3. The stock is already trading at a historical discount and Goldman sees no threat to earnings


Embedded below is Goldman Sachs' full research note on Apple (AAPL):



You can download a .pdf copy here.

For more on AAPL, head to our in-depth post on what this means for Apple investors, as well as our summary of the hedge funds that own the most AAPL shares.

Goldman Sachs & Hedge Funds Bullish On Tower Stocks

While we don't typically highlight shifts in analyst sentiment, we found some moves out of Goldman Sachs late last week intriguing as they were out positive on tower stocks. They raised price targets on American Tower (AMT) from $52 to $53, on SBA Communications (SBAC) from $40 to $43, and on Crown Castle (CCI) from $42 to $46. While AMT is rated a 'buy,' SBAC in particular is on Goldman's Conviction Buy List.

With their updated coverage, Goldman also added Crown Castle to their Conviction Buy List. They believe that CCI trades at a discount to peers and note that shares have recently underperformed. Goldman also feels that of the tower companies, CCI is the most likely to increase guidance. So, now why did this recent adjustment catch our eye? Well, because plenty of hedge funds own these names, of course!

In our hedge fund portfolio tracking series we've noted that a sizable concentration of long/short equity hedge funds have built up large positions in these various tower companies. Now, before we begin, keep in mind that these funds are set to update their portfolio disclosures with the SEC in the next few weeks so their portfolios could have changed drastically. But for now, we want to focus on the data we have, as this has been a building trend for a few quarters now. Here's what we've found:

John Griffin's Blue Ridge Capital has held shares of Crown Castle for over 3 quarters now. It had previously been their 17th largest US equity holding but most recently CCI was their 6th largest position as they added to their stake in the third quarter of 2009.

David Stemerman's Conatus Capital has previously owned both American Tower and Crown Castle. Their most recent portfolio disclosures show they currently prefer SBAC and CCI (their 17th & 18th largest positions), as they sold out of AMT in favor of those names.

Lee Hobson's Highside Capital Management has owned American Tower (AMT) for at least three quarters now, although it has slipped from their 8th largest holding 3 quarters ago to now their 12th largest holding most recently (SBAC was their 14th largest).

Chase Coleman's Tiger Global has owned American Tower for the past few quarters and it has hovered around their 7th and 10th largest US equity holding. They had last sold some shares when we covered Tiger's portfolio.

Matt Iorio's White Elm Capital had CCI as their third largest US equity holding when we looked at their portfolio via 13F filing and we noted they had also started a new position in SBAC.

Chris Shumway's hedge fund Shumway Capital Partners has been involved with all three in some fashion as they were recently selling out of CCI, reducing their SBAC holdings and starting a new position in AMT which we noticed when looking at their portfolio.


So, quite a few prominent names involved in tower stocks as you can see (and that's not even all of them). Again, keep in mind that this data is set to be refreshed in a few weeks and we could see a completely different story then. However, the fact that many of the above funds have held various tower companies over the past three quarters should say something. We track fundamentally research driven hedge funds with longer-term investment timeframes in hope of finding their next big plays.

We've previously touched on how many of the 'Tiger Cub' funds often hold similar positions in their portfolios and this is no different. (A Tiger Cub is a fund started by someone who was previously involved with legendary hedge fund manager Julian Robertson's Tiger Management). In fact, hedge fund replicator Alphaclone even has a Tiger Cub portfolio that takes the most popular stocks amongst Tiger Cub hedge funds and combines them into a portfolio that outperforms the market by a wide margin. These tower stocks are by far some of their more common holdings.

So, given the recent bullishness out of Goldman Sachs on tower companies, we thought it would be prudent to examine the large hedge fund presence as well. We'll have to see if this theme continues when the new sets of portfolio disclosures come out in a few weeks. As always, we'll cover those in our hedge fund portfolio tracking series.

Goldman Sachs Conviction Buy List Changes

With the market ramping up the past few months, Goldman Sachs has been quite busy editing their coveted Conviction Buy List. For those unaware, Goldman's Buy List is simply a list of the names they deem to be 'the best' at present. They also have a Conviction Sell List, which outlines stocks to be avoided at all costs. Just last week, we went through and updated the changes to their Conviction Buy List. And, here we are yet again with another round of some additions and a lot of subtractions.

Before we begin, do note that we don't necessarily place too much weight on individual analyst calls. As evidenced by the massive market decline of 2008, many analysts were behind the ball and were reactive rather than proactive. As such, we take it all with a grain of salt. That said, we also realize that many of these reports can move markets and influence opinion of various stocks, which is why we cover them. As we like to say, you have to "trade the perception, not the reality."

Conviction Buy List

Additions to the Buy List: International Game Technology (IGT), Bank of New York Mellon (BK), Teradyne (TER), Tenneco (TEN), Devon Energy (DVN), Owens Illinois (OI), and Lincoln National (LNC).

Stocks removed from the Buy List: Federal Mogul (FDML), Penn National Gaming (PENN), Chesapeake Energy (CHK), Northern Trust (NTRS), PMC Sierra (PMCS), Biiogen Idec (BIIB), Gap (GPS), L-3 Communications (LLL), Dollar Tree (DLTR), EOG Resources (EOG) and W. W. Grainger (GWW).

There are a lot of moves listed above, but let's check in on some of the more extravagant and bold calls. Goldman has practically doubled IGT's price target from $11 to $20, which is somewhat hard to stomach given the fact that they supply casinos and Vegas is in massive amounts of pain. Originally, Goldman had IGT listed as neutral, so they've really changed their stance on this one. Interestingly enough, they removed Penn National Gaming (PENN) from their Buy List at the same time. While we realize that each company in the gaming segment should be treated as an individual entity, we can't help but notice the interesting dynamic here. Goldman still lists PENN as a buy, but it is no longer on their coveted list, most likely due to the recent earnings release.

In typical Wall Street fashion, we see that as the financials all rally back from the abyss, Goldman adds Bank of New York Mellon (BK) to their Conviction List. "Oh, everything's fine and dandy again, buy buy buy!" Where was this upgrade back on the lows? This is a textbook example of being reactionary rather than proactive. In fairness to them, we're being pretty harsh here because BK is only up 10% over the past 3 months and is considered to be in slightly better shape than most other financials out there. BK has surfaced in our coverage before when we looked at the gap between tangible common equity and tier 1 capital in some financials. While BK was added to their Conviction List, we curiously see Northern Trust (NTRS) removed from the Conviction List. Both of these financial institutions are perceived to be less risky and more stable than most of the other volatile financials out there. As such, it's interesting to note that Goldman currently favors BK over NTRS.

We also noted that Chesapeake Energy (CHK) has also been removed from the Conviction List, but still retains a buy rating from Goldman. You'll remember that last week we touched on the highest paid CEOs of 2008 and Aubrey McClendon of CHK controversially topped the list.

Also, we see that Biogen Idec (BIIB) has been removed from the Conviction Buy List. We highlight this because longer-term readers of ours will know that we've documented a large hedge fund presence in this name. Hedge fund Shumway Capital Partners had BIIB as their 5th largest holding in the fourth quarter of 2008. Additionally, rabblerouser and well-known activist Carl Icahn has a sizable position in BIIB, as he looks to shake things up there. Goldman still remains a regular buy rating on the name.

In another sizable call from Goldman, they have upgraded Tenneco (TEN) from neutral to buy and have added it to the Conviction List. Their price target on the name is now $10, way up from their previous $2.10 price target. Tenneco designs automotive emission controls and clearly Goldman sees a lot of upside in this name. In fact, their upgrade alone pretty much sent the stock up 10%.

In one last big call, we also see Goldman's big change of heart on shares of Lincoln National (LNC) as they upgrade it from sell all the way up to buy and add it to their Conviction List. This move is very perplexing, seeing how shares of LNC are already up over 80% in the last month. Again, we ask, where was this upgrade a month ago?

That about covers the major moves this time around, as we saw a lot of names removed from the Conviction Buy List. Make sure you also check out our update from last week where we outlined some of the other recent changes to Goldman's Conviction List. We'll continue to track the major movements on Goldman's coveted lists.

Goldman Sachs Conviction Buy List Updates: May 2009

We used to cover Goldman Sachs' Conviction Buy & Sell lists pretty frequently on the blog, but then we became so inundated with hedge fund tracking that we never had the time. But now, with the 4th quarter 2008 hedge fund portfolio tracking behind us, we've got some spare time before the Q1 2009 portfolios are released and we're swamped again.

Here's the caveat with this coverage: we don't normally place a ton of weight on individual analyst calls and upgrades/downgrades. That said, we are very cognizant that they often move markets and have to at least be monitored. As such, we've covered Goldman Sachs' list because for whatever reason, everyone loves a "V.I.P." or "Best of" and "Worst of" list. So, Goldman's lists are essentially the cream of the crop in either direction. If they add it to their Conviction Buy List, they love it, and if they add it to the Conviction Sell List, they (at least for the moment) hate it. That much is self-explanatory but we just wanted to give a preface for those unaware. Now, to the changes:

Conviction Buy List

The bulk of their recent changes were made to their Conviction Buy List. As the month of May begins, Goldman has decided to ambush everyone with a ton of changes.

Here are the names they have just recently added to their Conviction Buy List: Liz Claiborne (LIZ), Massey Energy (MEE), Joy Global (JOYG), and Research in Motion (RIMM).

And, here are the names that Goldman has removed from their Conviction Buy List: Mastercard (MA).

Their addition of Claiborne to the list is interesting given that they have doubled their price target on the stock from $3.30 to $7.20. Is it just us, or did the economy NOT get 100% better overnight? Apparently all the Wall Street wives and girlfriends who had cut back on their purchases of make-up are rampantly buying again. Previously, Claiborne was rated as neutral but now graces their Conviction Buy List. This seems to stick with the market theme of the past few months of what we crassly call "sh*t rallies." Essentially, all the horribly beaten down stocks with poor fundamentals and poor outlooks are rallying for hardly any reason other than that they are oversold and are hopeful that the economy will rebound a.s.a.p.

Goldman removed Mastercard from the Conviction Buy List, but still retains a 'buy' rating on the name. More than anything, this is due to a combination of the recent earnings release, valuation, and taking some profits off the table after the rally. Interestingly enough, Mastercard (and Visa too) are holdings currently present in our Market Folly portfolio that we created based on hedge fund cloning. Our portfolio has seen a total return of over 190% since mid-2002 and has annualized returns of 17%. Year to date for 2009, our portfolio is outperforming the S&P by a handsomely wide margin, and Mastercard and Visa are certainly to thank for part of that.

We don't have a problem with this Goldman removing MA from the Buy List, as we recently sold some of our Visa (V) into the earnings release pop, as shares have rallied over the past few months. We post all of our portfolio updates in our Twitter stream, so definitely follow us on Twitter if you're not already. Again, MA is still rated a buy, but no longer graces the Conviction List.

Massey Energy (MEE) was also added to their Conviction Buy List as Goldman sees shares more than doubling from their previous $12 price target to a new target of $26. Massey was previously rated as Neutral and now graces the Buy List. And, as we'll touch on below, this upgrade was a part of a sector-wide coal upgrade on Goldman's part. But, it definitely appears as if Massey is their favorite at the moment.

Sticking to the energy and raw material meme, we see that they also added Joy Global (JOYG) to their Conviction Buy List. Joy provides the equipment and servicing related to the mining industry and since Goldman is bullish on the Coal industry, they're projecting somewhat of a trickle-down effect where Joy will see more action as the Coal companies ramp up. Goldman had just recently upgraded Joy from neutral to buy back in late April. But, they've now essentially upgraded it again by adding it to their Conviction List. Also, interestingly enough, we had noted that in Q4 2008, numerous hedge funds had sold out of Joy Global. We'll have to see if they have reversed course when they release their Q1 '09 holdings.

Last, but not least, they've also added Research in Motion (RIMM) to the list and have only mildly adjusted the price target to $85, up from $82. We're not quite sure what exactly has changed or what merited this move, but oh well. We've noted that previously RIMM was hedge fund Maverick Capital's 9th largest holding.

Also, we wanted to touch a major move by Goldman that undoubtedly help shake up the Coal industry yesterday (5/4/09). We couldn't help but notice that coal stocks were all rallying hard, and Goldman is partially responsible for this as they upgraded the entire American coal sector to 'Attractive' from 'Neutral.' And, as we mentioned above, Massey Energy in particular was even added to the Conviction Buy List. Stocks in the specific sector who were all seeing action include: Patriot Coal (PCX), Arch Coal (ACI), Consol Energy (CNX), Alpha Natural Resources (ANR), Peabody Energy (BTU), and Foundation Coal (FCL) among others.

Other Recent Moves

The names mentioned above all were added/subtracted from the list here in the first few days of May. But, in fairness of playing catch-up, we also wanted to quickly list which names Goldman also added/subtracted from their Conviction Lists at the end of April and on the 1st of May.

Further additions to the Conviction Buy List: Brinker (EAT), Activision (ATVI), Och-Ziff (OZM), & CVS Caremark (CVS).

Further removals from the Conviction Buy List: DR Horton (DHI) and ITT (ITT).

So, there you have it. You are now all caught up with Goldman Sachs' Conviction Buy & Sell Lists. (That is, until they release the next batch of changes). From here on out we'll try and update these lists, provided that our hedge fund tracking doesn't get in the way.

Quick Goldman Sachs Conviction Lists Update

Yesterday, we saw that Goldman Sachs made a few changes to their Conviction Lists. Notably, they added Wyeth (WYE) to the buy list, giving the stock a breakup value of $50 a share. They currently have a price target of $46 on the shares. Additionally, Autoliv (ALV) was removed from the conviction buy list. But, they still retain a normal 'buy' rating on the name. You can check out the rest of the recent updates to the GS conviction buy and sells lists here and here.

Taken from Google Finance, Wyeth (WYE) is "engaged in the discovery, development, manufacture, distribution and sale of a line of products in three primary businesses: Wyeth Pharmaceuticals (Pharmaceuticals), Wyeth Consumer Healthcare (Consumer Healthcare), and Fort Dodge Animal Health (Animal Health)."

Autoliv (ALV) is "a supplier of automotive safety systems with a range of product offerings, including modules and components for passenger and driver-side airbags, side-impact airbag protection systems, seatbelts, steering wheels, safety electronics, whiplash protection systems and child seats, as well as night vision systems and other active safety systems."

Goldman Sachs Conviction Lists Update

A few more changes were made to the Goldman Sachs Conviction Buy list early this week. Firstly, Arcelor Mittal (MT) was added to the Conviction Buy List. Schlumberger (SLB) was also added to the buy list with a new price target of $59. Schlumberger, as we've detailed here on Market Folly, has a heavy concentration of hedge fund ownership, including the likes of Boone Pickens' BP Capital, Stephen Mandel's Lone Pine Capital, and many more funds.

Additionally, Humana (HUM) was removed from the buy list, but the firm still maintains a regular 'buy' rating on the stock. Transocean (RIG) was also removed from the Conviction Buy list, having been added to the list just recently back in September.

Boeing (BA) was added to the Conviction Sell List. Lastly, HealthNet (HNT) was removed from the Conviction Sell list.

If you've missed them, we've detailed previous changes that were made to Goldman's coveted lists on October 27th here, as well as the changes from October 20th here.

Goldman Sachs Conviction Buy & Sell Updates

Late last week, Goldman Sachs made some changes to their coveted Conviction Buy and Sell lists. They were very active in the steel sector, adding Steel Dynamics (STLD) to the conviction buy list and then putting US Steel (X) on their conviction sell list. Lastly, Goldman also removed Alcatel Lucent (ALU) from the conviction buy list, but still rates the company as a normal 'buy.'

Goldman has been very busy the last few weeks adding and subtracting names from their lists as the volatility picks up and the market landscape changes. We have detailed more of Goldman's moves here and more additions to their conviction buy list here.

Analyst Calls & Goldman Sachs Conviction Buy List

I've said before that I typically don't place too much weight on analyst calls, but today numerous analyst calls caught my eye and I wanted to post them up.

Firstly, in the oil arena, there were a few active analysts who revealed a myriad of opinions. Firstly, Morgan Stanley upgraded Transocean (RIG) to Overweight, citing that they think the credit crunch gives them an advantage, as smaller drillers will struggle to finance projects. This makes sense to me just given the fact that RIG is a behemoth in the drilling space now. But, I wouldn't cite it as one of the main reasons they will outperform. They've got tons of rigs already and have other ones scheduled to come off construction in coming years. RIG is easily one of my favorite long-term plays due to their dominant market positioning, their ability to raise dayrates fairly consistently, and the armada of rigs that they will have coming online in the near future.

Back in September, RIG was added to Goldman Sachs' Conviction Buy List. Shares have been demolished as of late, offering a possible opportunity for those with a long-term bullish thesis on oil and deepwater drilling. Boone Pickens' BP Capital had RIG as their 2nd largest holding as of last quarter. RIG has been trampled partly due to the decrease in the price of oil and partly due to forced selling by various hedge fund and mutual fund names. Overall, I figure RIG is a solid buy as long as oil remains above $70 a barrel, which gives them enough room to still maintain or increase the high dayrates they charge. They are seeing operating margins of 46% and return on equity of 38%. Their valuation is absurdly cheap, but I won't dwell on that given the fact that in this market, valuation got thrown out the window a long time ago. And, the cheap can always become even cheaper. But, the fact is that this company has solid fundamentals going forward long-term. They are seeing quarterly revenue growth of 116% and quarterly earnings growth of 101% on a year over year basis. They do have a lot of debt, but their strong cashflow generation should alleviate any major stress from that.

There was also a bevy of other oil related calls today by an analyst from Deutsche Bank. They downgraded tons of oil names, citing a worldwide recession in 2009. They have cut oil price forecasts to $60 per barrel in '09 and $58 per barrel in '10. They wrote, "This view implies that the marginal oil company will make zero profit for the next two years. It implies leveraged oil companies may go bankrupt. It implies GDP-sensitive (ie refiners/chemicals) companies will suffer. Ultimately, it strongly suggests upheaval in oil-revenue dependent states." While anything is possible considering the grave state of numerous economies worldwide, I still do not think a worldwide recession is in the cards. This will have to be continually evaluated as we receive new data each quarter, but I think this is a slightly harsh call. Should a worldwide recession emerge though, their call makes sense in that the leveraged companies will find it increasingly difficult. They have downgraded a myriad of names, including Marathon (MRO), Conoco Phillips (COP), Suncor (SU), and Hess (HES) among others. Its interesting to now note that they only have "buys" on two oil names: Occidental (OXY) and Canadian Natural Resources (CNQ). OXY is a name that has seen vast hedge fund ownership, including by that of Atticus Capital, Caxton Associates, Tudor Investment Corp, and BP Capital, among many others.

Lastly, Goldman Sachs was out making changes again to its Conviction Buy List. They added Waste Management (WMI) to the list, and removed Allied Waste (AW) from the list. However, they still maintain a 'buy' rating on AW (just not a 'conviction buy'). Additionally, they also added Marsh & McLennan (MMC) and Applied Materials (AMAT) to their Conviction Buy List.

Goldman Sachs Conviction Buy List: Adds KMB, Removes HLF

Goldman Sachs yesterday made some changes to its Conviction Buy List. They added Kimberly Clark (KMB) to the buy list and removed Herbalife (HLF) from the list.

Taken from Google Finance, KMB is "a global health and hygiene company. The Company is engaged in the manufacturing and marketing of a range of health and hygiene products around the world."

And, HLF is "a global network marketing company that sells weight management, nutritional supplement, energy and fitness products, and personal care products."